$4.28
0.05[1.18%]
At close: Apr 26
$4.28
0[0.00%]
After Hours: 4:00PM EDT
Applied Therapeutics
(NASDAQ:APLT)Latest News for Applied Therapeutics Stock (NASDAQ:APLT)
Applied Therapeutics Stock (NASDAQ: APLT)
Categories: All
Thursday, April 11, 2024
Thursday, April 04, 2024
Monday, April 01, 2024
- FDA Presses Delay Button For Applied Therapeutics' First Potential Marketed Drug For Rare DiseaseVandana Singh - Apr 1, 2024, 12:30PM
- Why Doma Holdings Shares Are Trading Higher By Around 34%; Here Are 20 Stocks Moving PremarketAvi Kapoor - Apr 1, 2024, 8:08AM
- 12 Health Care Stocks Moving In Monday's Pre-Market SessionBenzinga Insights - Apr 1, 2024, 8:08AM
- Applied Therapeutics shares are trading lower after the company announced that the FDA extended the review period for the NDA for govorestat for the treatment of Classic Galactosemia by three months.Benzinga Newsdesk - Apr 1, 2024, 7:38AM
- Oxford Industries Posts Weak Results, Joins Applied Therapeutics And Other Big Stocks Moving Lower In Monday's Pre-Market SessionAvi Kapoor - Apr 1, 2024, 5:13AM
Friday, March 29, 2024
Thursday, March 28, 2024
- Applied Therapeutics shares are trading lower after the company announced that the FDA extended the review period for the NDA for govorestat for the treatment of Classic Galactosemia by three months.Benzinga Newsdesk - Mar 28, 2024, 4:50PM
- Applied Therapeutics Says FDA Has Extended Review Period For NDA For Govorestat (AT-007) For Treatment Of Classic Galactosemia By Three Months; PDUFA Target Action Date November 28, 2024Benzinga Newsdesk - Mar 28, 2024, 4:32PM
Tuesday, March 26, 2024
Friday, March 22, 2024
Friday, March 15, 2024
Monday, March 11, 2024
Wednesday, March 06, 2024
- UBS Maintains Buy on Applied Therapeutics, Raises Price Target to $12Benzinga Newsdesk - Mar 6, 2024, 12:38PM
- Applied Therapeutics: Q4 Earnings InsightsBenzinga Insights - Mar 6, 2024, 8:55AM
- Applied Therapeutics Expects That Its Cash And Cash Equivalents Of $49.9M, Combined With The Proceeds From The February 2024 Private Placement Of $100M Is Expected To Provide Cash Runway Into The First Half 2026Benzinga Newsdesk - Mar 6, 2024, 7:24AM
- Applied Therapeutics FY EPS $(1.42) Beats $(1.44) Estimate, Sales $9.99M Miss $10.67M EstimateBenzinga Newsdesk - Mar 6, 2024, 7:21AM
Thursday, February 29, 2024
Wednesday, February 28, 2024
- Why Bumble Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Wednesday's Mid-Day SessionAvi Kapoor - Feb 28, 2024, 2:02PM
- Advance Auto Parts Reports Q4 Results, Joins B&G Foods, Vipshop, ADT And Other Big Stocks Moving Higher On WednesdayAvi Kapoor - Feb 28, 2024, 11:37AM
- FDA Grants Review Date For Applied Therapeutics' First Commercial Product For Rare Metabolic DisorderVandana Singh - Feb 28, 2024, 11:01AM
- Applied Therapeutics shares are trading higher after the company announced FDA acceptance and priority review of the NDA for govorestat for the treatment of Classic Galactosemia. The company also announced a $100 million private placement.Benzinga Newsdesk - Feb 28, 2024, 9:03AM
- Applied Therapeutics Announces $100M Private PlacementBenzinga Newsdesk - Feb 28, 2024, 8:06AM
- Applied Therapeutics Announces FDA Acceptance And Priority Review Of New Drug Application For Govorestat For Treatment Of Classic GalactosemiaBenzinga Newsdesk - Feb 28, 2024, 8:05AM
Thursday, February 22, 2024
- Applied Therapeutics shares are trading higher after Leerink Partners initiated coverage on the stock with an Outperform rating and a $12 price target.Benzinga Newsdesk - Feb 22, 2024, 11:44AM
- Leerink Partners Initiates Coverage On Applied Therapeutics with Outperform Rating, Announces Price Target of $12Benzinga Newsdesk - Feb 22, 2024, 7:45AM
Monday, February 19, 2024
Friday, February 16, 2024
- Applied Therapeutics shares are trading higher after the company on Thursday released interim 12-month results from the ongoing Phase 3 INSPIRE trial, in which the primary and several key secondary endpoints were achieved.Benzinga Newsdesk - Feb 16, 2024, 3:24PM
- 12 Health Care Stocks Moving In Friday's Intraday SessionBenzinga Insights - Feb 16, 2024, 12:31PM
Thursday, February 15, 2024
- Why Is Rare Disease-Focused Applied Therapeutics Stock Trading Higher Today?Vandana Singh - Feb 15, 2024, 3:25PM
- 12 Health Care Stocks Moving In Thursday's Pre-Market SessionBenzinga Insights - Feb 15, 2024, 8:05AM
- Applied Therapeutics Announced Interim 12-month Results From Ongoing Phase 3 INSPIRE Trial Of Oral Govorestat (AT-007) For Sorbitol Dehydrogenase Deficiency, In Which Primary And Several Key Secondary Endpoints Were AchievedBenzinga Newsdesk - Feb 15, 2024, 7:06AM
Thursday, January 25, 2024
Friday, January 05, 2024
- Crude Oil Rises Over 2%; Constellation Brands Posts Downbeat SalesAvi Kapoor - Jan 5, 2024, 2:30PM
- Why Applied Therapeutics Shares Are Trading Lower By Over 35%? Here Are Other Stocks Moving In Friday's Mid-Day SessionAvi Kapoor - Jan 5, 2024, 1:13PM
- 12 Health Care Stocks Moving In Friday's Intraday SessionBenzinga Insights - Jan 5, 2024, 12:31PM
- Applied Therapeutics shares are trading lower after the company announced topline results of the ARISE-HF Phase 3 trial of AT-001 in Diabetic Cardiomyopathy.Benzinga Newsdesk - Jan 5, 2024, 12:20PM
- Dow Turns Lower; ISM Services PMI Falls In DecemberAvi Kapoor - Jan 5, 2024, 12:11PM
- Applied Therapeutics' Diabetes-Associated Heart Disease Drug Fails In Phase 3 Study, Stock PlungesVandana Singh - Jan 5, 2024, 10:30AM
- US Stocks Higher; Payrolls Increase By 216,000 In DecemberAvi Kapoor - Jan 5, 2024, 9:50AM
- 12 Health Care Stocks Moving In Friday's Pre-Market SessionBenzinga Insights - Jan 5, 2024, 8:05AM
- Why Dermata Therapeutics Shares Are Trading Higher By Over 57%; Here Are 20 Stocks Moving PremarketAvi Kapoor - Jan 5, 2024, 8:03AM
- Franklin Covey Shares Fall After Q1 Results, Joins Theravance Biopharma, Voyager Therapeutics And Other Big Stocks Moving Lower In Friday's Pre-Market SessionAvi Kapoor - Jan 5, 2024, 6:19AM
Thursday, January 04, 2024
- 12 Health Care Stocks Moving In Thursday's After-Market SessionBenzinga Insights - Jan 4, 2024, 4:31PM
- Applied Therapeutics Says Difference Between Active And Placebo Treated Groups (0.30 Ml/Kg/Min) In ARISE-HF Phase 3 Study Of AT-001 Was Not Statistically Significant (P=0.210)Benzinga Newsdesk - Jan 4, 2024, 4:17PM
- Applied Therapeutics Reports Topline Results From ARISE-HF Phase 3 Study Of AT-001 In Diabetic CardiomyopathyBenzinga Newsdesk - Jan 4, 2024, 4:06PM